PES2020-Prosj.etabl.støtte H2020
SN: the first blood biomarker to accurately stratify mortality risk in patients with cardiac arrhythmia
CardiNor is developing an innovative clinical diagnostic test to measure blood concentration of Secretoneurin (SN), a globally patented biomarker that provides unmatched insight into the mechanisms of arrhythmia risk, with prognostic capacity to accurately stratify patients with heart failure int...